Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12

J Yorke, S H Moosavi, C Shuldham, P W Jones, J Yorke, S H Moosavi, C Shuldham, P W Jones

Abstract

Rationale: Dyspnoea is a debilitating and distressing symptom that is reflected in different verbal descriptors. Evidence suggests that dyspnoea, like pain perception, consists of sensory quality and affective components. The objective of this study was to develop an instrument that measures overall dyspnoea severity using descriptors that reflect its different aspects.

Methods: 81 dyspnoea descriptors were administered to 123 patients with chronic obstructive pulmonary disease (COPD), 129 with interstitial lung disease and 106 with chronic heart failure. These were reduced to 34 items using hierarchical methods. Rasch analysis informed decisions regarding further item removal and fit to the unidimensional model. Principal component analysis (PCA) explored the underlying structure of the final item set. Validity and reliability of the new instrument were further assessed in a separate group of 53 patients with COPD.

Results: After removal of items with hierarchical methods (n = 47) and items that failed to fit the Rasch model (n = 22), 12 were retained. The "Dyspnoea-12" had good internal reliability (Cronbach's alpha = 0.9) and fit to the Rasch model (chi(2) p = 0.08). Items patterned into two groups called "physical"(n = 7) and "affective"(n = 5). In the separate validation study, Dyspnoea-12 correlated with the Hospital Anxiety and Depression Scale (anxiety r = 0.51; depression r = 0.44, p<0.001, respectively), 6-minute walk distance (r = -0.38, p<0.01) and MRC (Medical Research Council) grade (r = 0.48, p<0.01), and had good stability over time (intraclass correlation coefficient = 0.9, p<0.001).

Conclusion: Dyspnoea-12 fulfills modern psychometric requirements for measurement. It provides a global score of breathlessness severity that incorporates both "physical" and "affective" aspects, and can measure dyspnoea in a variety of diseases.

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Illustration of logit (ie, severity) value for each item. *Indicates item loading onto the “physical” component identified with principal component analysis (PCA). †Indicates item loading onto the “affective” component identified with PCA. The value attached to each descriptor is the logit (ie, severity) associated with that descriptor (negative values indicate milder, positive values indicate more severe). By convention, in Rasch analysis the severity scale is centred on zero logits. Note: these logit values are not used to score the instrument; they are shown here to illustrate the different relative severity of the items.
Figure 2
Figure 2
Mean (+95%CI) of total Dyspnoea-12 scores (D12-TOTAL), Borg-intensity (Borg-INT) and Borg-distress scores (Borg-DIS) at each Medical Research Council (MRC) dyspnoea grade for all three conditions combined (n = 358). Ratings for all three measures increased progressively with similar gradients of between 8% and 10% of full scale per increment in MRC grade.

References

    1. American Thoracic Society Dyspnea: mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 1999;159:321–40
    1. Wilson RC, Jones PW. Differentiation between the intensity of breathlessness and the distress it evokes in normal subjects during exercise. Clin Sci 1991;80:65–70
    1. Banzett RB, Pedersen SH, Schwartzstein RM, et al. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med 2008;177:1384–90
    1. Fierro-Carrion G, Mahler DA, Ward J, et al. Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. Chest 2004;125:77–84
    1. Lansing RW, Moosavi SH, Banzett RB. Measurement of dyspnea: word labelled visual analogue scale vs. verbal ordinal scale. Respir Physiol Neurobiol 2003;134:77–83
    1. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exer 1982;14:377–81
    1. Mahler DA, Ward J, Fierro-Carrion G, et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. J COPD 2004;1:165–72
    1. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581–6
    1. Jones PW, Quirk FH, Baveystock, et al A self-complete measure of health status for chronic airflow limitation. The St. George”s Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321–7
    1. Guyatt GH, Berman LB, Townsend M. Long-term outcome after respiratory rehabilitation. CMAJ 1987;137:1089–95
    1. Yorke J. Dyspnoea and pain: an interesting analogy. J Clin Nurs 2008;17:841–2
    1. Banzett RB, Moosavi SH. Dyspnea and pain: similarities and contrasts between two very unpleasant sensations. Am Pain Soc Bull 2001;11:6–8
    1. Smith J, Albert P, Bertella E, et al. Qualitative aspects of breathlessness in health and disease. Thorax 2009;64:713–8
    1. Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable sensations of breathlessness in patients with shortness of breath. Am Rev Respir Dis 1990;142:1009–1014
    1. Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1996;154:1357–63
    1. Wilcock A, Crosby V, Hughes A, et al. Descriptors of breathlessness in patients with cancer and other cardiorespiratory diseases. J Pain Symptom Manage 2002;23:182–189
    1. Garrard A, William M. The language of dyspnoea: a systematic review. Int J Appl Health Sci Pract 2008;6:1540–80
    1. Parshall MB, Welsh JD, Brockopp DY, et al. Reliability and validity of dyspnea sensory quality descriptors in heart failure patients treated in an emergency department. Heart Lung 2001;30:57–65
    1. von Leupoldt A, Balewski S, Peterson S, et al. Verbal descriptors of dyspnea in patients with COPD at different intensity levels of dyspnea. Chest 2007;132:141–7
    1. Caroci A, Lareau SC. Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure. Heart Lung 2004;33:102–10
    1. Bailey PH. The dyspnea-anxiety-dyspnea cycle—COPD patients’ stories of breathlessness: “It’s scary/when you can’t breathe”. Qual Health Res 2004;14:760–78
    1. Skevington SM, Pilaar M, Routh D, et al. On the language of breathlessness. Psychol Health 1997;12:677–89
    1. Michaels C, Meek PM. The language of breathing among individuals with chronic obstructive pulmonary disease. Heart Lung 2004;33:390–400
    1. O’Leary CJ, Jones PW. The influence of decisions made by developers on health status questionnaire content. Qual Life Res 1998;7:545–50
    1. Andrich D, Lyne A, Sheridan B, et al. RUMM2020 Perth, Australia: RUMM Laboratory, 2003
    1. Rasch G. Probabilistic models for some intelligence and attainment tests Danish Institute of Educational Research, 1960
    1. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648–54
    1. Pallant J, Tennant A. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale. Br J Clin Psychol 2007;46:1–18
    1. Kline P. An easy guide to factor analysis New York: Routledge, 1994
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–70
    1. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009;167:53–60
    1. Livermore N, Butler JE, Sharpe L, et al. Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:7–12

Source: PubMed

3
Abonnere